Glenmark Pharmaceuticals Limited (GLENMARK.BO)
INR 1541.0
(1.1%)
INR 1541.0
(1.1%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 67.56 Billion INR | -45.96% |
| 2022 | 61.73 Billion INR | 11.11% |
| 2021 | 55.55 Billion INR | 9.08% |
| 2020 | 50.93 Billion INR | 0.26% |
| 2019 | 50.8 Billion INR | 8.52% |
| 2018 | 46.81 Billion INR | 9.74% |
| 2017 | 42.65 Billion INR | -5.4% |
| 2016 | 45.09 Billion INR | 24.06% |
| 2015 | 36.34 Billion INR | 0.11% |
| 2014 | 36.3 Billion INR | 21.57% |
| 2013 | 29.86 Billion INR | 32.81% |
| 2012 | 22.48 Billion INR | 9.23% |
| 2011 | 20.58 Billion INR | 56.07% |
| 2010 | 13.19 Billion INR | 41.33% |
| 2009 | 9.33 Billion INR | 30.61% |
| 2008 | 7.14 Billion INR | 27.9% |
| 2007 | 5.58 Billion INR | 41.69% |
| 2006 | 3.94 Billion INR | 58.33% |
| 2005 | 2.49 Billion INR | 26.51% |
| 2004 | 1.96 Billion INR | 40.76% |
| 2003 | 1.39 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.35 Billion INR | -3.09% |
| 2023 FY | 33.36 Billion INR | -45.96% |
| 2023 Q4 | 8.62 Billion INR | -51.67% |
| 2023 Q1 | 16.31 Billion INR | 25.29% |
| 2023 Q2 | 16.42 Billion INR | 0.64% |
| 2023 Q3 | 17.83 Billion INR | 8.63% |
| 2022 Q4 | 13.02 Billion INR | -26.35% |
| 2022 Q3 | 17.68 Billion INR | 12.36% |
| 2022 Q2 | 15.73 Billion INR | 10.57% |
| 2022 FY | 61.73 Billion INR | 11.11% |
| 2022 Q1 | 14.23 Billion INR | 18.7% |
| 2021 Q3 | 14.95 Billion INR | -1.29% |
| 2021 Q2 | 15.14 Billion INR | 12.49% |
| 2021 Q1 | 13.46 Billion INR | 43.22% |
| 2021 Q4 | 11.99 Billion INR | -19.82% |
| 2021 FY | 55.55 Billion INR | 9.08% |
| 2020 Q1 | 11.36 Billion INR | 7.36% |
| 2020 FY | 50.93 Billion INR | 0.26% |
| 2020 Q2 | 14.18 Billion INR | 24.87% |
| 2020 Q3 | 14.32 Billion INR | 0.98% |
| 2020 Q4 | 9.4 Billion INR | -34.36% |
| 2019 Q3 | 13.78 Billion INR | -3.04% |
| 2019 Q4 | 10.58 Billion INR | -23.22% |
| 2019 FY | 50.8 Billion INR | 8.52% |
| 2019 Q1 | 12.22 Billion INR | 4.95% |
| 2019 Q2 | 14.21 Billion INR | 16.28% |
| 2018 FY | 46.81 Billion INR | 9.74% |
| 2018 Q1 | 11.03 Billion INR | -4.65% |
| 2018 Q3 | 12.96 Billion INR | -0.4% |
| 2018 Q2 | 13.01 Billion INR | 17.98% |
| 2018 Q4 | 11.64 Billion INR | -10.15% |
| 2017 Q3 | 11.56 Billion INR | -1.24% |
| 2017 FY | 42.65 Billion INR | -5.4% |
| 2017 Q4 | 11.56 Billion INR | 0.01% |
| 2017 Q2 | 11.71 Billion INR | 5.69% |
| 2017 Q1 | 11.08 Billion INR | -17.26% |
| 2016 Q2 | 12.39 Billion INR | 28.16% |
| 2016 Q3 | 12.35 Billion INR | -0.34% |
| 2016 FY | 45.09 Billion INR | 24.06% |
| 2016 Q4 | 13.39 Billion INR | 8.43% |
| 2016 Q1 | 9.67 Billion INR | -27.14% |
| 2015 FY | 36.34 Billion INR | 0.11% |
| 2015 Q2 | 10.15 Billion INR | 18.41% |
| 2015 Q3 | 9.55 Billion INR | -5.85% |
| 2015 Q4 | 13.27 Billion INR | 38.88% |
| 2015 Q1 | 8.57 Billion INR | -27.14% |
| 2014 Q1 | 7.59 Billion INR | -16.22% |
| 2014 FY | 36.3 Billion INR | 21.57% |
| 2014 Q4 | 11.76 Billion INR | 24.79% |
| 2014 Q3 | 9.42 Billion INR | 9.65% |
| 2014 Q2 | 8.6 Billion INR | 13.31% |
| 2013 Q4 | 9.05 Billion INR | 19.92% |
| 2013 FY | 29.86 Billion INR | 32.81% |
| 2013 Q2 | 7.07 Billion INR | 14.74% |
| 2013 Q1 | 6.17 Billion INR | -17.87% |
| 2013 Q3 | 7.55 Billion INR | 6.71% |
| 2012 Q3 | 6.24 Billion INR | 10.06% |
| 2012 Q4 | 7.51 Billion INR | 20.35% |
| 2012 FY | 22.48 Billion INR | 9.23% |
| 2012 Q1 | 5.34 Billion INR | -10.93% |
| 2012 Q2 | 5.67 Billion INR | 6.19% |
| 2011 Q4 | 5.99 Billion INR | 5.14% |
| 2011 FY | 20.58 Billion INR | 56.07% |
| 2011 Q3 | 5.7 Billion INR | 0.0% |
| 2010 FY | 13.19 Billion INR | 41.33% |
| 2009 FY | 9.33 Billion INR | 30.61% |
| 2008 FY | 7.14 Billion INR | 27.9% |
| 2007 FY | 5.58 Billion INR | 41.69% |
| 2006 FY | 3.94 Billion INR | 58.33% |
| 2005 FY | 2.49 Billion INR | 26.51% |
| 2004 FY | 1.96 Billion INR | 40.76% |
| 2003 FY | 1.39 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ajanta Pharma Limited | 30.46 Billion INR | -121.793% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -6047.851% |
| Sigachi Industries Limited | 579.88 Million INR | -11551.26% |
| Bal Pharma Limited | 389.89 Million INR | -17229.026% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -3080.71% |
| Medico Remedies Limited | 161.84 Million INR | -41646.46% |
| Lasa Supergenerics Limited | 291.17 Million INR | -23104.043% |
| Venus Remedies Limited | 1.91 Billion INR | -3425.789% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -2095.922% |
| Alpa Laboratories Limited | 156.14 Million INR | -43169.573% |
| Nectar Lifesciences Limited | 625.55 Million INR | -10700.758% |
| Shilpa Medicare Limited | 2.18 Billion INR | -2998.435% |
| Aarti Drugs Limited | 1.16 Billion INR | -5687.182% |
| Lupin Limited | 95.67 Billion INR | 29.38% |
| Aurobindo Pharma Limited | 39.23 Billion INR | -72.203% |
| Zydus Lifesciences Limited | 43.17 Billion INR | -56.493% |
| Windlas Biotech Limited | 1 Billion INR | -6612.714% |
| Suven Life Sciences Limited | 109.75 Million INR | -61461.859% |
| Eris Lifesciences Limited | 4.94 Billion INR | -1266.882% |
| Valiant Laboratories Limited | 36.28 Million INR | -186083.527% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | -702.703% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | -1375.296% |
| Ipca Laboratories Limited | 13.91 Billion INR | -385.552% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -4660.646% |
| Achyut Healthcare Limited | 1.6 Million INR | -4199038.595% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 56.179% |
| Bajaj HealthCare Limited | 985.34 Million INR | -6756.902% |
| RPG Life Sciences Limited | 1.63 Billion INR | -4031.1% |
| Mankind Pharma Limited | 23.15 Billion INR | -191.819% |
| Laurus Labs Limited | 3.01 Billion INR | -2144.059% |
| Piramal Pharma Limited | 19.91 Billion INR | -239.28% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -7069.377% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -215.395% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -325.743% |
| Unichem Laboratories Limited | 6.72 Billion INR | -904.542% |
| Sequent Scientific Limited | 2.9 Billion INR | -2228.345% |
| Novartis India Limited | 470.1 Million INR | -14272.291% |
| Wanbury Limited | 1.16 Billion INR | -5719.844% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -4716.415% |
| Wockhardt Limited | 6.4 Billion INR | -955.69% |
| Themis Medicare Limited | 782.85 Million INR | -8530.479% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -8635.876% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -367.443% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -480.414% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 29.531% |
| Divi's Laboratories Limited | 14.17 Billion INR | -376.811% |
| NATCO Pharma Limited | 10.05 Billion INR | -571.745% |
| Gufic Biosciences Limited | 1.07 Billion INR | -6169.226% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -6048.902% |
| Ind-Swift Limited | 946.56 Million INR | -7037.809% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -2155.597% |
| FDC Limited | 5.34 Billion INR | -1163.228% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -146282.139% |
| Granules India Limited | 7.18 Billion INR | -840.694% |
| Medicamen Biotech Limited | 335.16 Million INR | -20058.351% |
| Alkem Laboratories Limited | 32.83 Billion INR | -105.769% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -2498.221% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -416713.045% |
| Brooks Laboratories Limited | 51.18 Million INR | -131912.778% |
| Megasoft Limited | 49.52 Million INR | -136316.05% |
| ZIM Laboratories Limited | 1.01 Billion INR | -6569.326% |
| Strides Pharma Science Limited | 9.16 Billion INR | -637.415% |
| Neuland Laboratories Limited | 2.92 Billion INR | -2206.143% |
| Morepen Laboratories Limited | 1.98 Billion INR | -3299.539% |
| Hikal Limited | 2.48 Billion INR | -2617.414% |
| Indoco Remedies Limited | 4.74 Billion INR | -1322.771% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -2097.637% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -16282.085% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -9892.522% |
| Hester Biosciences Limited | 908.84 Million INR | -7334.107% |